Variants conferring risk of atrial fibrillation on chromosome 4q25

Nature

Volumn 448, Issue 7151, 2007, Pages 353-357

  Gudbjartsson, Daniel F ^a   Arnar, David O ^b   Helgadottir, Anna ^a   Gretarsdottir, Solveig ^a   Holm, Hilma ^b   Sigurdsson, Asgeir ^a   Jonasdottir, Adalbjorg ^a   Baker, Adam ^a   Thorleifsson, Gudmar ^a   Kristjansson, Kristleifur ^a   Palsson, Arnar ^a   Blondal, Thorarinn ^a   Sulem, Patrick ^a   Backman, Valgerdur M ^a   Hardarson, Gudmundur A ^a   Palsdottir, Ebba ^a   Helgason, Agnar ^a   Sigurjonsdottir, Runa ^b   Sverrisson, Jon T ^c   Kostulas, Konstantinos ^d   Ng, Maggie C Y ^e   Baum, Larry ^e   So, Wing Yee ^e   Wong, Ka Sing ^e   Chan, Juliana C N ^e   Furie, Karen L ^f   Greenberg, Steven M ^f   Sale, Michelle ^f   Kelly, Peter ^f   MacRae, Calum A ^f   Smith, Eric E ^f   Rosand, Jonathan ^f   Hillert, Jan ^d   Ma, Ronald C W ^e   Ellinor, Patrick T ^f   Thorgeirsson, Gudmundur ^b   Gulcher, Jeffrey R ^a   Kong, Augustine ^a   Thorsteinsdottir, Unnur ^a   Stefansson, Kari ^a   more..

^a DECODE GENETICS   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c Akureyri Regional Hospital   (Iceland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL;

CARDIOVASCULAR DISEASE; CHROMOSOME; GENE; GENOME; HEALTH RISK; MORBIDITY; MORTALITY; MUTATION; RISK FACTOR;

ADULT; AGED; ARTICLE; CHINESE; CHROMOSOME 4Q; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ASIA; CHINA; EURASIA; EUROPE; FAR EAST; HONG KONG;

EID: 34447515621     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature06007     Document Type: Article

References (24)

1. Go, A. S. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J. Am. Med. Assoc. 285, 2370-2375 (2001).
2. Miyasaka, Y. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114, 119-125 (2006).
3. Arnar, D. O. et al. Familial aggregation of atrial fibrillation in Iceland. Eur. Heart J. 27, 708-712 (2006).
4. Fox, C. S. et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. J. Am. Med. Assoc. 291, 2851-2855 (2004).
5. Ellinor, P. T., Yoerger, D. M., Ruskin, J. N. & MacRae, C. A. Familial aggregation in lone atrial fibrillation. Hum. Genet. 118, 179-184 (2005).
6. Chen, Y. H. et al. KCNQ1 gain-of-function mutation in familial fibrillation. Science 299, 251-254 (2003).
7. Yang, Y. et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am. J. Hum. Genet. 75, 899-905 (2004).
8. Xia, M. et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem. Biophys. Res. Commun. 332, 1012-1019 (2005).
9. Olson, T. M. et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum. Mol. Genet. 15, 2185-2191 (2006).
10. Hong, K., Bjerregaard, P., Gussak, I. & Brugada, R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J. Cardiovasc. Electrophysiol. 16, 394-396 (2005).
11. Ellinor, P. T. et al. Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart 90, 1487-1488 (2004).
12. Ellinor, P. T., Petrov-Kondratov, V. I., Zakharova, E., Nam, E. G. & MacRae, C. A. Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med. Genet. 7, 70 (2006).
13. Franco, D. & Campione, M. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc. Med. 13, 157-163 (2003).
14. Faucourt, M., Houliston, E., Besnardeau, L., Kimelman, D. & Lepage, T. The pitx2 homeobox protein is required early for endoderm formation and nodal signaling. Dev. Biol. 229, 287-306 (2001).
15. Mommersteeg, M. T. et al. Molecular pathway for the localized formation of the sinoatrial node. Circ. Res. 100, 354-362 (2007).
16. The International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
17. Waldo, A. L. The interrelationship between atrial fibrillation and atrial flutter. Prog. Cardiovasc. Dis. 48, 41-56 (2005).
18. Zini, S. et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl Acad. Sci. USA 93, 11968-11973 (1996).
19. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nature Genet. 35, 131-138 (2003).
20. Falk, C. T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227-233 (1987).
21. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748 (1959).
22. Grant, S. F. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 38, 320-323 (2006).
23. Yang, X. et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 30, 65-70 (2007).
24. Baum, L. et al. Methylenetetrahydrofolate reductase gene A222V polymorphism and risk of ischemic stroke. Clin. Chem. Lab. Med. 42, 1370-1376 (2004).